Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan
Author(s) -
Wen-Hsin Hsih,
Mengyu Cheng,
MaoWang Ho,
Chia-Huei Chou,
PoChang Lin,
Francesco Bianchi-Demicheli,
Wei–Chih Liao,
ChihYu Chen,
Lih-Ying Leong,
Ni Tien,
HuanCheng Lai,
YiChyi Lai,
MinChi Lu
Publication year - 2020
Publication title -
journal of microbiology immunology and infection
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.223
H-Index - 57
eISSN - 1995-9133
pISSN - 1684-1182
DOI - 10.1016/j.jmii.2020.03.008
Subject(s) - medicine , covid-19 , respiratory system , infection control , epidemiology , isolation (microbiology) , disease , coronavirus , pediatrics , intensive care medicine , infectious disease (medical specialty) , microbiology and biotechnology , biology
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of infection, Taiwan Centers for Disease Control initiated testing of SARS-CoV-2 on January 24th 2020 for persons suspected with this disease. Until February 28th, 43 flu-like symptomatic patients were screened in China Medical University Hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom